ARRY
Price
$15.82
Change
-$0.30 (-1.86%)
Updated
Dec 6, 6:59 PM EST
89 days until earnings call
FBRX
Price
$0.50
Change
+$0.01 (+2.04%)
Updated
Dec 6, 6:59 PM EST
104 days until earnings call
Ad is loading...

Analysis and predictions ARRY vs FBRX

Header iconARRY vs FBRX Comparison
Open Charts ARRY vs FBRXBanner chart's image
Array Technologies
Price$15.82
Change-$0.30 (-1.86%)
Volume$2.39M
CapitalizationN/A
Forte Biosciences
Price$0.50
Change+$0.01 (+2.04%)
Volume$38.41K
CapitalizationN/A
View a ticker or compare two or three
ARRY vs FBRX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ARRY vs. FBRX commentary
Dec 07, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a StrongSell and FBRX is a Buy.

COMPARISON
Comparison
Dec 07, 2023
Stock price -- (ARRY: $15.82 vs. FBRX: $0.51)
Brand notoriety: ARRY and FBRX are both not notable
ARRY represents the Electrical Products, while FBRX is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARRY: 66% vs. FBRX: 193%
Market capitalization -- ARRY: $2.23B vs. FBRX: $16.22M
ARRY [@Electrical Products] is valued at $2.23B. FBRX’s [@Biotechnology] market capitalization is $16.22M. The market cap for tickers in the [@Electrical Products] industry ranges from $181.26B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Electrical Products] industry is $3.79B. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARRY’s FA Score shows that 1 FA rating(s) are green whileFBRX’s FA Score has 0 green FA rating(s).

  • ARRY’s FA Score: 1 green, 4 red.
  • FBRX’s FA Score: 0 green, 5 red.
According to our system of comparison, FBRX is a better buy in the long-term than ARRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 4 TA indicator(s) are bullish while FBRX’s TA Score has 5 bullish TA indicator(s).

  • ARRY’s TA Score: 4 bullish, 5 bearish.
  • FBRX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, FBRX is a better buy in the short-term than ARRY.

Price Growth

ARRY (@Electrical Products) experienced а +6.10% price change this week, while FBRX (@Biotechnology) price change was +10.73% for the same time period.

The average weekly price growth across all stocks in the @Electrical Products industry was +0.98%. For the same industry, the average monthly price growth was -1.09%, and the average quarterly price growth was -21.01%.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.65%. For the same industry, the average monthly price growth was +5.77%, and the average quarterly price growth was +27.21%.

Reported Earning Dates

ARRY is expected to report earnings on Mar 05, 2024.

FBRX is expected to report earnings on Mar 20, 2024.

Industries' Descriptions

@Electrical Products (+0.98% weekly)

The industry produces a diverse range of electricity-powered equipment, appliances and components, catering to both households and industries. The products include power, distribution and specialty transformers; electric motors, generators and motor-generator sets; switchgear and switchboard apparatus; light bulbs, tubes, fittings and electric signs etc. Consumer income, construction spending, and industrial production are major drivers of demand for this industry’s products. Large companies tend to have economies of scale in production, marketing, and distribution, while smaller companies can potentially carve out their own market through niche or specialty offerings. The US electrical products manufacturing industry includes about 5,700 establishments (single-location companies and units of multi-location companies) with combined annual revenue of about $125 billion. (according to a study published in First Research). Emerson Electric Co., Hubbell Incorporated and Eaton Corporation plc are major electrical products makers in the U.S.

@Biotechnology (+6.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ARRY with price predictions.
OPEN
A.I.dvisor published
a Summary for FBRX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ARRY($2.23B) has a higher market cap than FBRX($16.2M). ARRY has higher P/E ratio than FBRX: ARRY (38.17) vs FBRX (0.58). ARRY YTD gains are higher at: -18.158 vs. FBRX (-48.730). ARRY has higher annual earnings (EBITDA): 275M vs. FBRX (-31.04M). ARRY has more cash in the bank: 174M vs. FBRX (46.2M). ARRY has higher revenues than FBRX: ARRY (1.64B) vs FBRX (0).
ARRYFBRXARRY / FBRX
Capitalization2.23B16.2M13,778%
EBITDA275M-31.04M-886%
Gain YTD-18.158-48.73037%
P/E Ratio38.170.586,586%
Revenue1.64B0-
Total Cash174M46.2M377%
Total Debt698MN/A-
FUNDAMENTALS RATINGS
ARRY vs FBRX: Fundamental Ratings
ARRY
FBRX
OUTLOOK RATING
1..100
520
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
81100
SMR RATING
1..100
28100
PRICE GROWTH RATING
1..100
8065
P/E GROWTH RATING
1..100
9847
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARRY's Valuation (71) in the Biotechnology industry is in the same range as FBRX (99) in the null industry. This means that ARRY’s stock grew similarly to FBRX’s over the last 12 months.

ARRY's Profit vs Risk Rating (81) in the Biotechnology industry is in the same range as FBRX (100) in the null industry. This means that ARRY’s stock grew similarly to FBRX’s over the last 12 months.

ARRY's SMR Rating (28) in the Biotechnology industry is significantly better than the same rating for FBRX (100) in the null industry. This means that ARRY’s stock grew significantly faster than FBRX’s over the last 12 months.

FBRX's Price Growth Rating (65) in the null industry is in the same range as ARRY (80) in the Biotechnology industry. This means that FBRX’s stock grew similarly to ARRY’s over the last 12 months.

FBRX's P/E Growth Rating (47) in the null industry is somewhat better than the same rating for ARRY (98) in the Biotechnology industry. This means that FBRX’s stock grew somewhat faster than ARRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYFBRX
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
59%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
66%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 4 days ago
74%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 16 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRNCX9.580.05
+0.52%
T. Rowe Price Intl Disciplined Eq Adv
SJCAX24.13-0.10
-0.41%
Steward Large Cap Core A
RICEX49.21-0.21
-0.42%
American Funds Invmt Co of Amer R4
CHTVX18.66-0.09
-0.48%
Invesco Charter R5
MAPAX26.50-0.95
-3.47%
MainStay WMC Value A

FBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBRX has been loosely correlated with FBIO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if FBRX jumps, then FBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBRX
1D Price
Change %
FBRX100%
+3.58%
FBIO - FBRX
35%
Loosely correlated
+4.87%
AXON - FBRX
31%
Poorly correlated
+0.27%
EIGR - FBRX
28%
Poorly correlated
-3.56%
ARRY - FBRX
28%
Poorly correlated
-1.86%
SRNEQ - FBRX
27%
Poorly correlated
+1.87%
More